Unsere Publikationen

6-sulpho LacNAc(+) dendritic cells accumulate in various inflammatory, but not ischaemic conditions of the central nervous system

Link
https://doi.org/10.1111/nan.12313
Tags
Neuroimmunologie
Jahr
2016
Autoren
Thomas K, Metz I, Tumani H, Brück W, Ziemssen T.
Verlag
Neuropathol Appl Neurobiol 2016;42(4):394-398.
Zum Eintrag

Acute effects of alemtuzumab infusion in patients with active relapsing-remitting MS

Link
https://doi.org/10.1212/nxi.0000000000000228
Tags
Multiple SkleroseMS Behandlung
Jahr
2016
Autoren
Thomas K, Eisele J, Rodriguez-Leal FA, Hainke U, Ziemssen T.
Verlag
Neurol Neuroimmunol Neuroinflamm 2016;3(3).
Zum Eintrag

Laquinimod in the treatment of relapsing remitting multiple sclerosis

Link
https://doi.org/10.1080/17425255.2016.1179279
Tags
Multiple SkleroseMS Behandlung
Jahr
2016
Autoren
Hainke U, Thomas K, Ziemssen T.
Verlag
Expert Opin Drug Metab Toxicol 2016;12(6):701-709.
Zum Eintrag

New insights into the pharmacokinetics and pharmacodynamics of natalizumab treatment for patients with multiple sclerosis, obtained from clinical and in vitro studies

Link
https://doi.org/10.1186/s12974-016-0635-2
Tags
Multiple SkleroseMS Behandlung
Jahr
2016
Autoren
Sehr T, Proschmann U, Thomas K, Marggraf M, Straube E, Reichmann H, Chan A, Ziemssen T.
Verlag
J Neuroinflammation. 2016 Jun 27;13(1):164.
Zum Eintrag

Hes3 expression in the adult mouse brain is regulated during demyelination and remyelination

Link
https://doi.org/10.1016/j.brainres.2016.03.014
Tags
Andere
Jahr
2016
Autoren
Toutouna L, Nikolakopoulou P, Poser SW, Masjkur J, Arps-Forker C, Troullinaki M, Grossklaus S, Bosak V, Friedrich U, Ziemssen T, Bornstein SR, Chavakis T, Androutsellis-Theotokis A.
Verlag
Brain Res. 2016 Jul 1;1642:124-130.
Zum Eintrag

Therapy satisfaction and adherence in patients with relapsing-remitting multiple sclerosis: the THEPA-MS survey

Link
https://doi.org/10.1177/1756285616634247
Tags
Multiple SkleroseManagement & Science
Jahr
2016
Autoren
Haase R, Kullmann JS, Ziemssen T.
Verlag
Ther Adv Neurol Disord 2016;9(4):250-263.
Zum Eintrag

Design of TRUST, a non-interventional, multicenter, 3-year prospective study investigating an integrated patient management approach in patients with relapsing-remitting multiple sclerosis treated with natalizumab

Link
https://doi.org/10.1186/s12883-016-0625-0
Tags
Multiple SkleroseMS Behandlung
Jahr
2016
Autoren
Ziemssen T, Gass A, Wuerfel J, Bayas A, Tackenberg B, Limmroth V, Linker R, Mäurer M, Haas J, Stangel M, Meergans M, Harlin O, Hartung HP.
Verlag
BMC Neurol. 2016 Jul 12;16:98.
Zum Eintrag

Rationale, design, and methods of a non-interventional study to establish safety, effectiveness, quality of life, cognition, health-related and work capacity data on Alemtuzumab in multiple sclerosis patients in Germany (TREAT-MS)

Link
https://doi.org/10.1186/s12883-016-0629-9
Tags
Multiple SkleroseMS Behandlung
Jahr
2016
Autoren
Ziemssen T, Engelmann U, Jahn S, Leptich A, Kern R, Hassoun L, Thomas K.
Verlag
BMC Neurol. 2016 Jul 19;16:109.
Zum Eintrag
1 2 3

Publikationen durchsuchen

Publikationen filtern

Filter
Tags
Multiple Sklerose
MS Behandlung
Mobilität
Autonomes Nervensystem & Neuroendokrinologie
Neuroimmunologie
Herzratenvariabilität
Baroreflexsensitivität
Management & Science
eHealth
Gesundheitsökonomie
Andere
Zeige alleVerstecke
Jahr
-